Tardif, J., Rhéaume, E., Lemieux Perreault, L., Grégoire, J. C., Feroz Zada, Y., Asselin, G., . . . Dubé, M. (2015). Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib. Circulation. Cardiovascular genetics, 8(2), 372-382. https://doi.org/10.1161/CIRCGENETICS.114.000663
Chicago Style (17th ed.) CitationTardif, Jean-Claude, et al. "Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib." Circulation. Cardiovascular Genetics 8, no. 2 (2015): 372-382. https://doi.org/10.1161/CIRCGENETICS.114.000663.
MLA (9th ed.) CitationTardif, Jean-Claude, et al. "Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib." Circulation. Cardiovascular Genetics, vol. 8, no. 2, 2015, pp. 372-382, https://doi.org/10.1161/CIRCGENETICS.114.000663.